FDA Product Code PLL: Submucosal Injection Agent
Intended For Use In Gastrointestinal Endoscopic Procedures For Submucosal Lift Of Polyps, Adenomas, Early-stage Cancers Or Other Gastrointestinal Mucosal Lesions, Prior To Excision With A Snare Or Endoscopic Device.
Leading manufacturers include The Standard Co., Ltd., Endoclot Plus Co., Ltd. and Ovesco Endoscopy AG.
FDA 510(k) Cleared Submucosal Injection Agent Devices (Product Code PLL)
About Product Code PLL - Regulatory Context
510(k) Submission Activity
10 total 510(k) submissions under product code PLL since 2015, with 10 receiving FDA clearance (average review time: 182 days).
Submission volume has remained relatively stable over the observed period, with 1 submissions in the last 24 months.
FDA 510(k) Review Time - PLL Product Code
FDA review times for PLL submissions have been consistent, averaging 167 days recently vs 184 days historically.
PLL devices are reviewed by the Gastroenterology & Urology panel. Browse all Gastroenterology & Urology devices →